The DFS between CAP1-high-expression level and low-expression level in lung cancer patients was also compared in TCGA and data revealed that NSCLC patients with high CAP1 expression level gained a shorter DFS time (Fig. 2b). Here, CAP1 is linked to non-small cell lung carcinoma.